Sri Lanka NMRA Medical Device Registration Consultants

Sri Lanka NMRA medical device registration is required before devices can be imported, manufactured or sold in Sri Lanka. Medfins International helps Indian and overseas manufacturers appoint a local agent, prepare the product registration dossier and supporting site evidence, and plan the import licensing steps, so that applications to the National Medicines Regulatory Authority are complete and well organised.

What is Sri Lanka NMRA medical device registration?

The National Medicines Regulatory Authority (NMRA) regulates medicines, medical devices and borderline products in Sri Lanka under the National Medicines Regulatory Authority Act No. 5 of 2015 and its regulations. A medical device must be registered with the NMRA before it is imported, manufactured, stored for sale or sold, unless a specific exemption or waiver applies.

Technical evaluation is supported by an expert committee for medical devices, and approval leads to entry of the product in the NMRA register. Registered products can then be imported under the relevant NMRA licensing controls.

Who needs NMRA registration?

• Foreign manufacturers, including Indian manufacturers, who must appoint a Sri Lankan business entity as their local authorised agent.
• Local importers and distributors, who usually act as that agent and hold the registration.
• Local manufacturers of medical devices.

The local agent handles registration, importation, sales and product quality issues, including complaints and recalls. Because the registration is linked to the agent, manufacturers should agree roles and a process for changing agent in writing.

Classification and scope

The NMRA applies a risk-based approach and published guidance distinguishes between device categories such as listed (low-risk) devices, general medical devices and in vitro diagnostic devices (IVDs), with additional data expected for sterile and active devices. The category decides the dossier content and whether foreign manufacturing site approval is needed.

The NMRA also offers a product categorisation process to confirm whether a borderline product is regulated as a device. We review the latest NMRA guidance for your product before preparing the file.

Dossier routes

• Consolidated dossier – foreign manufacturing site approval (FMSA) together with the product registration dossier (PRD), for general devices and IVDs that need site approval.
• PRD only – where separate site approval is not required, including listed devices.
• Reliance pathway – introduced by the NMRA in late 2025 for devices already approved in recognised reference jurisdictions, such as the EU, USA, UK, Canada, Australia and Japan, allowing a more streamlined evaluation.

Documents required

• Letter of authorisation from the manufacturer appointing the local agent
• Business registration documents of the local agent
• Valid free sale certificate from the country of origin
• ISO 13485 certificate (ISO 9001 may be accepted for some listed devices)
• Evidence of registration in other countries, including reference jurisdictions for the reliance pathway
• Summary technical documentation (STED) describing the device, intended use, models and design
• Risk analysis to ISO 14971
• Test reports and certificates of analysis; stability data where applicable
• Sterilisation validation for sterile devices; electrical safety and EMC data for active devices; performance evaluation for IVDs; software validation where relevant
• Labels and instructions for use, and samples when requested

Registration process

1. Product review – confirm device status, category and the right dossier route.
2. Appoint the local agent – select a Sri Lankan entity with the capacity to import and distribute.
3. Gap analysis – map your CE, US FDA or CDSCO documentation to NMRA requirements.
4. Dossier preparation – compile the PRD, and the FMSA file where required.
5. Submission – the local agent submits through the NMRA’s designated channel. The NMRA uses its eNMRA digital platform and has, at times, accepted manual submissions.
6. Evaluation – respond to NMRA queries within the stop-clock period allowed, which NMRA guidance currently sets at two months.
7. Registration – first-time products may receive provisional registration, followed by full registration after further evaluation.
8. Import licensing – the local agent imports registered devices under the applicable NMRA licences and permits.

Import licence and waiver of registration

Registration and importation are linked but separate. The local agent needs the relevant NMRA licensing to import and distribute registered devices. For urgent or special needs, unregistered devices may in limited cases be imported under a waiver of registration, which requires its own application and supporting evidence. A waiver is not a substitute for registration for regular commercial supply.

Timelines and what affects them

NMRA review times can be long for new products, particularly where full evaluation and site approval are needed. The reliance pathway is intended to shorten this for devices with recognised approvals. Timelines depend on:

• Device category and dossier route
• Whether a reference-jurisdiction approval supports the application
• Completeness of the dossier and consistency of documents
• Speed of query responses within the stop-clock period
• NMRA workload and committee meeting schedules

Common reasons for delays and queries

• Expired free sale certificates or ISO 13485 certificates
• Model names that differ between certificates, labels and technical files
• Missing sterilisation, electrical safety or IVD performance data
• Local agent documents incomplete or not matching the authorisation letter
• Missing the stop-clock response deadline

How Medfins International supports you

Medfins International has delivered 175+ regulatory projects for 100+ clients across 15+ countries, led by a CQI and IRCA certified ISO 13485 Lead Auditor. For Sri Lanka we provide:

• Category and dossier route assessment, including reliance pathway eligibility
• PRD and FMSA dossier preparation from your CE marking or US FDA 510(k) files
• Quality system readiness through ISO 13485 support
• Local agent coordination and query management

To discuss your Sri Lanka launch, contact our regulatory team.

Frequently asked questions